REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY

Autor: I. V. Novikov, S. V. Madoyan, N. A. Demidova, Shostak Na, A. A. Klimenko, S. M. Sorokoletov
Jazyk: angličtina
Rok vydání: 2015
Předmět:
medicine.medical_specialty
lcsh:Diseases of the circulatory (Cardiovascular) system
pulmonary embolism
n-terminal brain natriuretic peptide
Diastole
RM1-950
тканевая миокардиальная допплерэхокардиография
Doppler echocardiography
right ventricle
диастолическая дисфункция
chronic thromboembolic pulmonary hypertension
Internal medicine
medicine.artery
pulmonary hypertension
medicine
Diseases of the circulatory (Cardiovascular) system
легочная гипертензия
тромбоэмболия легочной артерии
Pharmacology (medical)
правый желудочек
medicine.diagnostic_test
business.industry
lcsh:RM1-950
myocardial tissue doppler echocardiography
хроническая тромбоэмболическая легочная гипертензия
medicine.disease
Brain natriuretic peptide
Pulmonary hypertension
Pulmonary embolism
lcsh:Therapeutics. Pharmacology
lcsh:RC666-701
RC666-701
Pulmonary artery
N-концевой мозговой натрийуретический пептид
Cardiology
Chronic thromboembolic pulmonary hypertension
Observational study
diastolic dysfunction
Therapeutics. Pharmacology
Cardiology and Cardiovascular Medicine
business
Zdroj: Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 9, Iss 3, Pp 258-264 (2015)
ISSN: 2225-3653
1819-6446
Popis: Aim. To study the right heart remodeling and level of N-terminal brain natriuretic peptide (Nt-proBNP) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Material and methods. Patients (n=79) after pulmonary embolism were included into the study. The main group consisted of patients (n=43) with an increase in systolic pulmonary artery pressure (SPAP) >30 mm Hg: 30 (37.9%) patients had pulmonary hypertension (PH) degree I, and 13 (16.5%) — PH degree II–III. Group of comparison con- sisted of 36 patients expired pulmonary embolism and having SPAP 2) were detected in 19.4%, 16.7% and 61.5% of patients of comparison group, PH I and PH II–III patients, respectively. According to myocardial tissue Doppler echocardiography Em/Am
Databáze: OpenAIRE